These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3669015)

  • 1. Modulation of the antitumor activity by methyl substitutions in the series of 7H-pyridocarbazole monomers and dimers.
    Léon P; Garbay-Jaureguiberry C; Barsi MC; Le Pecq JB; Roques BP
    J Med Chem; 1987 Nov; 30(11):2074-80. PubMed ID: 3669015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor series.
    Garbay-Jaureguiberry C; Barsi MC; Jacquemin-Sablon A; Le Pecq JB; Roques BP
    J Med Chem; 1992 Jan; 35(1):72-81. PubMed ID: 1732535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
    Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
    Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
    Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
    J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles.
    Pelaprat D; Oberlin R; Le Guen I; Roques BP; Le Pecq JB
    J Med Chem; 1980 Dec; 23(12):1330-5. PubMed ID: 7452685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetrical bisintercalators as potential antitumor agents.
    Léon P; Garbay-Jaureguiberry C; Lambert B; Le Pecq JB; Roques BP
    J Med Chem; 1988 May; 31(5):1021-6. PubMed ID: 3283364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series.
    Garbay-Jaureguiberry C; Laugâa P; Delepierre M; Laalami S; Muzard G; Le Pecq JB; Roques BP
    Anticancer Drug Des; 1987 Apr; 1(4):323-35. PubMed ID: 3450302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
    Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
    J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.
    Delepierre M; Maroun R; Garbay-Jaureguiberry C; Igolen J; Roques BP
    J Mol Biol; 1989 Nov; 210(1):211-28. PubMed ID: 2585517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.
    Esnault C; Roques BP; Jacquemin-Sablon A; Le Pecq JB
    Cancer Res; 1984 Oct; 44(10):4355-60. PubMed ID: 6467197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain.
    Garbay-Jaureguiberry C; Esnault C; Delepierre M; Laugaa P; Laalami S; Le Pecq JB; Roques BP
    Drugs Exp Clin Res; 1987; 13(6):353-7. PubMed ID: 3652924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
    Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
    Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
    Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
    Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
    Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
    Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
    Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA-intercalating compound derived from 7H-pyridocarbazole: the structure of 10-methoxy-2-methyl-7H-pyrido[4,3-c]carbazolium iodide.
    Courseille C; Pelaprat D; Tsai CC
    Acta Crystallogr C; 1988 Dec; 44 ( Pt 12)():2154-6. PubMed ID: 3270555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
    Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
    Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
    Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
    J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent.
    Esnault C; Brown SC; Segal-Bendirdjian E; Coulaud D; Mishal Z; Roques BP; Le Pecq JB
    Biochem Pharmacol; 1990 Jan; 39(1):109-22. PubMed ID: 2297352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.